Related Experiment Video
Updated: Aug 31, 2026

A Rat Model of EcoHIV Brain Infection
Published on: January 21, 2021
HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration
Kunyan Zhang1, G Angus McQuibban, Claudia Silva
1Department of Clinical Neurosciences, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada.
Abstract:
The mechanisms of neurodegeneration that result in human immunodeficiency virus (HIV) type 1 dementia have not yet been identified. Here, we report that HIV-infected macrophages secrete the zymogen matrix metalloproteinase-2 (MMP-2), which is activated by exposure to MT1-MMP on neurons. Stromal cell-derived factor 1 alpha (SDF-1), a chemokine overexpressed by astrocytes during HIV infection, was converted to a highly neurotoxic protein after precise proteolytic processing by active MMP-2, which removed the N-terminal tetrapeptide. Implantation of cleaved SDF-1(5-67) into the basal ganglia of mice resulted in neuronal death and inflammation with ensuing neurobehavioral deficits that were abrogated by neutralizing antibodies to SDF-1 and an MMP inhibitor drug. Hence, this study identifies a new in vivo neurotoxic pathway in which cleavage of a chemokine by an induced metalloproteinase results in neuronal apoptosis that leads to neurodegeneration.
Insights
HIV-infected macrophages release matrix metalloproteinase-2 (MMP-2), which activates and cleaves a chemokine, causing neurotoxicity and neurodegeneration in HIV dementia. This pathway involves MMP-2, stromal cell-derived factor 1 alpha (SDF-1), and neuronal apoptosis.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Mechanisms underlying HIV-1 dementia remain unclear.
- HIV-1 infection impacts macrophage and astrocyte function.
Purpose of the Study:
- To elucidate the molecular mechanisms of neurodegeneration in HIV-1 dementia.
- To identify specific proteins and pathways involved in HIV-1-associated neurotoxicity.
Main Methods:
- Investigated the role of matrix metalloproteinase-2 (MMP-2) secreted by HIV-infected macrophages.
- Examined the activation of MMP-2 by neuronal MT1-MMP.
- Analyzed the processing of stromal cell-derived factor 1 alpha (SDF-1) by active MMP-2.
- Utilized in vivo mouse models with basal ganglia implantation of cleaved SDF-1(5-67).
- Assessed neurobehavioral deficits and inflammation in mice.
- Employed neutralizing antibodies to SDF-1 and MMP inhibitors for therapeutic assessment.
Main Results:
- HIV-infected macrophages secrete latent MMP-2, activated by neuronal MT1-MMP.
- Active MMP-2 cleaves SDF-1, generating a neurotoxic fragment (SDF-1(5-67)).
- Intracranial implantation of SDF-1(5-67) induced neuronal death, inflammation, and neurobehavioral deficits in mice.
- These deficits were reversed by SDF-1 antibodies and MMP inhibitors.
Conclusions:
- Identified a novel in vivo neurotoxic pathway in HIV-1 dementia.
- This pathway involves MMP-2-mediated cleavage of SDF-1, leading to neuronal apoptosis.
- Targeting MMP-2 or SDF-1 may offer therapeutic strategies for HIV-1-associated neurodegeneration.
Related Concept Videos
Cryptococcal Meningitis
Inhibitors of Virion Maturation and Assembly
Alzheimer Disease ll: Pathophysiology
Role of Matrix Metalloproteases in Degradation of ECM
A...
